MediciNova, Inc. Forecast, price target & analysts
MediciNova, Inc. Target price 2026 - Analyst rating & recommendation
MediciNova, Inc. Classifications & Recommendation
MediciNova, Inc. Price Target
| Target Price | $10.20 |
| Price | $2.58 |
| Potential |
295.35%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target MediciNova, Inc. 2027 .
The average MediciNova, Inc. target price is $10.20.
This is
295.35%
register free of charge
$11.55
347.67%
register free of charge
$6.06
134.88%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend MediciNova, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MediciNova, Inc. stock has an average upside potential 2027 of
295.35%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.41 | 0.53 |
| 28.12% | ||
| EBITDA Margin | -3,234.15% | -2,873.79% |
| 11.14% | ||
| Net Margin | -2,926.83% | -2,484.89% |
| 15.10% |
5 Analysts have issued a sales forecast MediciNova, Inc. 2026 . The average MediciNova, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an MediciNova, Inc. EBITDA forecast 2026. The average MediciNova, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 MediciNova, Inc. Analysts have issued a net profit forecast 2026. The average MediciNova, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.24 | -0.27 |
| 4.35% | 12.50% | |
| P/E | negative | |
| EV/Sales | 193.36 |
5 Analysts have issued a MediciNova, Inc. forecast for earnings per share. The average MediciNova, Inc. EPS is
This results in the following potential growth metrics and future valuations:
MediciNova, Inc....
Current MediciNova, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Roth Capital |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | May 04 2026 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Mar 23 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Jan 30 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Dec 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Roth Capital:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
May 04 2026 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Mar 23 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 16 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jan 30 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Dec 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
